San Raffaele
San Raffaele
Italy, Milan
Francesco Montorsi
34 years of experience
accreditations :
Clinic is certified :
Prostate cancer treatment cost in Italy is determined by the diagnostic baseline and chosen therapeutic modality. A PSA test typically costs $100 to $100, while a robotic da Vinci prostatectomy runs from $25,200 to $28,000. Total expenses depend on the cancer stage, hospital tier, and surgical approach. International patients can save 30-50% compared to US private healthcare. Top treatment centers are located in Milan, Rome, and Bologna.
Typical Prostate Cancer Treatment Costs in Italy
Bookimed Expert Insight: For high-precision requirements, robotic surgery at Ospedale San Carlo di Nancy is a top-rated choice. Patients seeking world-renowned experts should consider San Raffaele, where Professor Francesco Montorsi performs urological surgeries. If multidisciplinary care is needed, JCI-accredited Maria Cecilia Hospital provides specialized urological oncology. Early-stage patients benefit from standard laparoscopic options at San Donato Hospital to manage costs effectively.
| Italy | Turkey | Austria | |
| Transurethral resection of the prostate (TURP) | from $3,600 | from $3,580 | from $5,500 |
| Tomotherapy | from $32,000 | from $12,000 | from $30,000 |
| Robotic da Vinci prostatectomy | from $25,181 | from $17,000 | from $20,000 |
| Radiotherapy for prostate cancer | from $18,000 | from $4,000 | from $14,000 |
| Proton-beam therapy | from $70,000 | from $70,000 | from $80,000 |
Prof. Montorsi has performed over 8,000 urology surgeries, specializing in minimally invasive and robotic techniques for prostate cancer at San Raffaele.
Head of Radiotherapy at San Raffaele Hospital – Prof. Di Muzio specializes in high-precision hypofraction methods for prostate cancer, with over 33 years of experience of experience.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.
Dr. Gian Carlo Mattiucci is the Director of the Radiation Oncology Unit. He is an expert in advanced radiation therapies, such as Intensity Modulated Radiation Therapy, Stereotactic Radiation Therapy, Adaptive Radiation Therapy, and Brachytherapy. He focuses on treatment for upper gastrointestinal, prostate, and lung cancers. Dr. Mattiucci uses advanced imaging and works closely with other specialists to improve patient care.
He earned his medical degree from Università La Sapienza and completed his specialization in Radiation Oncology at Università Cattolica del Sacro Cuore in Rome. Dr. Mattiucci is an Assistant Professor at Università Cattolica. He also teaches in the ESTRO “Evidence Based Radiation Oncology” course and supports education and clinical progress in his field.
Written by Anna Leonova
Written by Olena Sikoza